Carl Zeiss Meditec AG wins patent infringement action on trifocal intraocular lens
VSY Biotechnology BV and its exclusive supplier Fritz Ruck Ophthalmologische Systeme GmbH were convicted by the court to recall all their trifocal lenses on the market and destroy all such lenses in their possession.
Intraocular lenses are used primarily to treat cataracts. In recent years, the development of innovative new lenses has considerably enhanced treatment options. Trifocal intraocular lenses such as the ZEISS AT LISA® tri and the AT LISA® tri toric enable patients to see well at all distances – often without them needing eyeglasses.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.